Cardiac Arrhythmia: Electrophysiology, risk factors, and pharmacology (Part I)

Apuntes

WEEK 4 - LECTURE 6 DRUG TREATMENT OF ARRHYTHMIA Dr Monica de Gaetano Ass. Prof. in Pharmacology School of Biomolecular & Biomedical Science UCD Conway Institute (F070) monica.degaetano@ucd.ie PHAR30110 – CARDIOVASCULAR & RENAL DISEASES 5 th February 2026 Lectures Syllabus Drug Treatment of Risk factor >> Underlying Condition >> Disease • Dyslipidaemia >> Atherosclerosis >> Angina >> Coronary Artery Disease • Hypertension • Arrhythmia • Cardiac Failure Cardiovascular Pharmacology teaching block - Overview Classes of Drugs  Lipid lowerings (Statins, PCSK9i)  Anti-Anginals [Nitrates; Beta-Blockers, Calcium Channel blockers (N.B.C.)]  Anti-hypertensives (Beta-blockers, CCC, RAAS-targeting, Diuretics)  Anti-arrhytmics (INOTROPICS AGENTS) Cardiovascular Pharmacology teaching block - Overview 3 ways of Lowering Blood Pressure (i) Reduce CO: ADRENOCEPTORS & BETA BLOCKERS (i) Reduce BV: RAAS system & RAS ANTAGONISTS / DIURETICS CALCIUM CHANNEL BLOCKERS (widely used) NITRATES (i) Reduce PVR: VASODILATORS DIURETICS dedicated lecture 05.03.26 Last Pharm Lecture Recap (Dr de Gaetano): ANTI-HYPERTENSIVE AGENTS  increase NO  increase relaxation  prevent Calcium entry  prevent contraction ...